Darzalex and Xarelto drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Darzalex and Xarelto. Common interactions include peripheral swelling among females and thrombocytopenia among males.

The phase IV clinical study analyzes what interactions people who take Darzalex and Xarelto have. It is created by eHealthMe based on reports of 318 people who take Darzalex and Xarelto from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 01, 2022

318 people who take Darzalex and Xarelto together, and have interactions are studied.


What is Darzalex?

Darzalex has active ingredients of daratumumab. eHealthMe is studying from 14,292 Darzalex users for its effectiveness, alternative drugs and more.

What is Xarelto?

Xarelto has active ingredients of rivaroxaban. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 197,025 Xarelto users for its effectiveness, alternative drugs and more.

Number of Darzalex and Xarelto reports submitted per year:

Darzalex and Xarelto drug interactions.

Darzalex and Xarelto drug interactions by gender *:

Click here to view

Darzalex and Xarelto drug interactions by age *:

Click here to view

Common conditions people have *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Darzalex and Xarelto?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Darzalex and Xarelto:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Darzalex interactions:

Browse all interactions between Darzalex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Xarelto interactions:

Browse all interactions between Xarelto and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on daratumumab and rivaroxaban (the active ingredients of Darzalex and Xarelto, respectively), and Darzalex and Xarelto (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Darzalex and Xarelto.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: